Samsung Removes Vascular Load Feature from Galaxy Watch in U.S., Shifts to Blood Pressure Trends
Samsung has removed the Vascular Load feature from its Galaxy Watch models in the U.S., replacing it with blood pressure trends, according to official statements from the company. The change, reported by GSMArena, marks a shift in the company’s approach to cardiovascular health monitoring on its wearable devices.
What Is Vascular Load and Why Was It Removed?
Vascular Load was designed to estimate arterial stiffness. It aimed to provide users with insights into cardiovascular health. However, the feature faced scrutiny from medical experts and regulatory bodies.
“The decision to remove Vascular Load was driven by ongoing reviews of its clinical validity and user feedback,” a Samsung spokesperson said in a statement. “We are prioritizing features that align with established medical guidelines and provide actionable insights for users.”
How Does the Shift to Blood Pressure Trends Affect Users?
The new focus on blood pressure trends replaces Vascular Load. This data is displayed as trends over time, allowing users to track fluctuations and share insights with healthcare providers. The feature leverages Samsung’s proprietary sensors and machine learning algorithms.
Healthcare professionals have mixed reactions. Users should still consult with physicians for accurate diagnosis.
What’s Next for Samsung’s Health Tech Strategy?
Samsung’s move aligns with broader industry trends toward simplifying health metrics for consumer devices. The company has not yet announced plans for new health features but hinted at “expanding its partnership with medical institutions to validate future innovations.”
Users with Galaxy Watch models will see the Vascular Load feature removed.
Why This Matters for Wearable Tech and Health Monitoring
The removal of Vascular Load underscores the challenges of integrating medical-grade features into consumer electronics. While wearables offer convenience, their data often lacks the rigor of clinical tools. This shift could influence how other companies balance innovation with regulatory compliance.
Samsung’s decision reflects a broader effort to align its products with evolving standards in digital health. As wearables become more integrated into healthcare, the line between consumer tech and medical devices will continue to blur, requiring careful navigation by manufacturers and regulators alike.